You are currently browsing the archives for the Jaime King category.

Jaime King on California’s Drug Transparency Law

Published on: Author: Robin Feldman

When Governor Jerry Brown signed California’s drug transparency law, Senate Bill 17 (SB-17), in 2017, the state took a crucial first step towards increased transparency and accountability in a landscape of skyrocketing prescription-drug prices. Not only does SB-17 require drug manufacturers and health insurers to disclose information about rising prescription-drug prices, but it also represents… Continue reading

Jaime King on the Anti-Competitive Potential of Cross-Market Mergers in Health Care

Published on: Author: Robin Feldman

What drives health care costs ever higher? Consolidation may be playing a key role. In this context, Professor Jaime King’s contribution to the St. Louis University Annual Health Law Symposium, “The Anti-Competitive Potential of Cross-Market Mergers in Health Care” (coauthored with Erin C. Fuse Brown), is a clarion call for antitrust authorities to consider seriously… Continue reading

Jaime King et al. on Freestanding Emergency Departments and the Healthcare Game

Published on: Author: Emily Murphy

The fragmented nature of the U.S. healthcare system creates many targets for criticism. Innovations such as freestanding emergency departments (EDs) have recently drawn fire from payers, policy makers, and professional organizations. In a new article in the Annals of Emergency Medicine titled “Don’t Hate the Player; Hate the Game,” Professor Jaime King (writing with physician… Continue reading